How much is Obinutuzumab reimbursed by medical insurance?

Obinutuzumab has entered the scope of Class B medical insurance through the relevant policies of the National Medical Insurance Administration after being launched in China, but it is only reimbursed for patients who meet the indications, including combination with chemotherapy for initial treatment of adult patients with stage 11, stage or IV follicular lymphoma with huge masses. Patients who achieve at least partial response are subsequently treated with obinutuzumab for maintenance treatment. The price of 1000mg (40ml)*1 bottle of Otuzumab original drug specifications listed in China may be around RMB 9,000. It is a strictly controlled drug. The reimbursement ratio is different in different regions. The price after reimbursement may be different. For specific reimbursement ratio, please consult the local medical insurance bureau or hospital.